Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): A critical update and consensus statement.

Important knowledge gaps remain and hamper the development of clinical guidelines. Several controversies were identified where consensus is lacking, and further harmonization between stakeholders is necessary. Finally, the need for randomized controlled comparative clinical trials in MRONJ resonates harder than ever to identify the best treatment for individual patients.